These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 25494485)

  • 1. Cardiac risks associated with antibiotics: azithromycin and levofloxacin.
    Lu ZK; Yuan J; Li M; Sutton SS; Rao GA; Jacob S; Bennett CL
    Expert Opin Drug Saf; 2015 Feb; 14(2):295-303. PubMed ID: 25494485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure.
    Assimon MM; Pun PH; Wang L; Al-Khatib SM; Brookhart MA; Weber DJ; Winkelmayer WC; Flythe JE
    Kidney Int; 2022 Oct; 102(4):894-903. PubMed ID: 35752324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
    Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
    Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appraisal of the cardiovascular risks of azithromycin: an observational analysis.
    Sutton SS; Hyche S; Magagnoli J; Hardin JW
    J Comp Eff Res; 2017 Sep; 6(6):509-517. PubMed ID: 28960092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.
    Rao GA; Mann JR; Shoaibi A; Bennett CL; Nahhas G; Sutton SS; Jacob S; Strayer SM
    Ann Fam Med; 2014; 12(2):121-7. PubMed ID: 24615307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-based approach to evaluating azithromycin use and cardiovascular risks.
    Wong E; Nguyen TV
    Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia.
    Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin and the risk of cardiovascular complications.
    Maisch NM; Kochupurackal JG; Sin J
    J Pharm Pract; 2014 Oct; 27(5):496-500. PubMed ID: 25374989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Azithromycin Use With Cardiovascular Mortality.
    Zaroff JG; Cheetham TC; Palmetto N; Almers L; Quesenberry C; Schneider J; Gatto N; Corley DA
    JAMA Netw Open; 2020 Jun; 3(6):e208199. PubMed ID: 32585019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin.
    Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA
    JAMA Netw Open; 2020 Sep; 3(9):e2016864. PubMed ID: 32930780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cardiovascular risk a concern when prescribing azithromycin?
    Sutton SS
    JAAPA; 2017 Jan; 30(1):11-13. PubMed ID: 28033168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice.
    Choi Y; Lim HS; Chung D; Choi JG; Yoon D
    Biomed Res Int; 2018; 2018():1574806. PubMed ID: 30406128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin and the risk of cardiovascular death.
    Ray WA; Murray KT; Hall K; Arbogast PG; Stein CM
    N Engl J Med; 2012 May; 366(20):1881-90. PubMed ID: 22591294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center.
    Lee RA; Guyton A; Kunz D; Cutter GR; Hoesley CJ
    J Hosp Med; 2016 Jan; 11(1):15-20. PubMed ID: 26287278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.
    Riddle MS; Connor P; Fraser J; Porter CK; Swierczewski B; Hutley EJ; Danboise B; Simons MP; Hulseberg C; Lalani T; Gutierrez RL; Tribble DR;
    Clin Infect Dis; 2017 Nov; 65(12):2008-2017. PubMed ID: 29029033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?
    Makaryus AN; Byrns K; Makaryus MN; Natarajan U; Singer C; Goldner B
    South Med J; 2006 Jan; 99(1):52-6. PubMed ID: 16466123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosis.
    Magaret AS; Salerno J; Deen JF; Kloster M; Mayer-Hamblett N; Ramsey BW; Nichols DP
    J Cyst Fibros; 2021 Mar; 20(2):e16-e18. PubMed ID: 33246911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular Repolarization.
    Täubel J; Prasad K; Rosano G; Ferber G; Wibberley H; Cole ST; Van Langenhoven L; Fernandes S; Djumanov D; Sugiyama A
    J Clin Pharmacol; 2020 Mar; 60(3):400-408. PubMed ID: 31637733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.